期刊文献+

反相离子对高效液相色谱法测定左卡尼汀注射液中杂质A的含量 被引量:2

An ion pair reversed phase high performance liquid chromatography method for determination of impurity A in levocarnitine injection
原文传递
导出
摘要 目的:建立离子对高效液相色谱法测定左卡尼汀注射液中杂质A的含量。方法:采用Zorbax SB-C18色谱柱(4.6 mm×250 mm,5μm),流动相为磷酸盐缓冲液[(取磷酸11.5 mL,加水约1800 mL,用1 mol.L-1氢氧化钠溶液调pH至3.0,加水至2000 mL),加庚烷磺酸钠1.1 g,振摇使溶解]-甲醇(95∶5),流速1.0 mL.min-1,检测波长为215 nm。结果:左卡尼汀杂质A与主药峰得到良好分离,分离度达到1.772,在1~100μg·mL-1的范围内,杂质A浓度与峰面积之间呈现良好线性关系,r2=0.9996(n=6),3批左卡尼汀注射液中杂质A的平均含量为0.0052%。结论:该方法简便、准确、专属,可用于该注射液的质量控制。 Objective: To establish a method to determine the impurity A content of levocarnitine injection by the ion pair high performance liquid chromatography.Methods: The Zorbax SB-C18 column(4.6 mm × 250 mm,5 μm) was used with a mobile phase consisting of phosphate buffer solution[(11.5 mL phosphoric acid was dissolved in 1800 mL water,adjusted to pH = 3.0 using 1 mol.L-1sodium hydroxide solution,and then brought up to full volume 2000 mL with water),finally 1.1 g sodium heptanesulfonate was added and dissolved by shaking] and methanol(95∶ 5) at a flow rate of 1.0 mL.min-1;the detection wavelength was 215 nm.Results: Levocarnitine and impurity A was completely separated by this method,and their resolution was 1.772.The linearity of peak area of impurity A was good in the range of 1-100 μg.mL-1(r2 = 0.9996,n = 6).The average content of impurity A in levocarnitine injection was 0.0052%.Conclusions: The established method is specific,accurate and convenient,which can be used for quality control of levocarnitine injection.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第7期1151-1156,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 左卡尼汀注射液 杂质A 氯化3-羧基-N N N-三甲基-2-丙烯-1-铵 离子对高效液相色谱法 有关物质控制 levocarnitine injection impurity A ion pair high performance liquid chromatography relative substances control
  • 相关文献

参考文献13

  • 1The National Drug Standard,New Drug Positive Standard(国家药品标准·新药转正标准).64(第64册):128.
  • 2EP 6.0.2008.2257.
  • 3USP32-NF27.2009.2766.
  • 4Matsumoto K,Ichitani Y,Ogasawara N, et al.Precolumn fluorescence derivatization of eamitine and aeylcarnitines with 4-(2-aminoethylamino)-7-nitro-2,1,3-benzoxadiazole. J Chromatogr A,1994,678:241.
  • 5De Witt P,Deias R,Muck S, et al. High-performance liquid chromatography and capillary electrophoresis of L-and D-carnitine by precolunm diastereomerie defivatization. J Chromatogr B Biomed Appl ,1994,657(1):67.
  • 6高立军,王涛,全东琴.高效液相色谱法测定左卡尼汀注射液的含量[J].科学技术与工程,2011,11(30):7494-7496. 被引量:4
  • 7孙永旭,陆丛笑,唐启令,曹玉,薛玉增,万秀霞,王春波.高效液相色谱法同时测定人血浆中左卡尼汀、乙酰左卡尼汀和丙酰左卡尼汀的浓度[J].中国药学杂志,2007,42(18):1425-1428. 被引量:7
  • 8Mardones C,Ríos A,Valcárcel M,et al.Separation of D/L-carnitine enantiomers by capillary electrophoresis.J Chromatogr A,1999,849(2):609.
  • 9赵亚明,李任,王得新,沈素.高效液相色谱法检测血浆左旋肉碱方法的建立[J].中国临床神经科学,2006,14(5):528-532. 被引量:20
  • 10Li K,Li W,Huang YF.Determination of free L-carnitinein human seminal plasma by high performance liquid chromatography with pre-column ultraviolet derivatization and its clinical application in male infertility.Clin Chim Acta,2007,378(5):159.

二级参考文献34

  • 1周建鸿.肉碱与婴儿配方食品[J].国外医学(卫生学分册),1994,21(5):290-293. 被引量:17
  • 2周书凤,何志谦.左旋肉碱——一种人体特定条件下的必需营养素[J].国外医学(卫生学分册),1996,23(1):33-36. 被引量:17
  • 3赵亚明,李任,王得新,沈素.高效液相色谱法检测血浆左旋肉碱方法的建立[J].中国临床神经科学,2006,14(5):528-532. 被引量:20
  • 4周建鸿,刘冬生.强化L-肉碱对幼鼠生长和脂肪代谢的影响[J].营养学报,1996,18(2):209-212. 被引量:17
  • 5The United States Pharmacopeial Convention. USP 24, (Vol 2 ) . Washington, D. C:United States Pharmacopeial Cony-ention Ine, 2000 : 961 -963.
  • 6Matsumoto K, Ichitani Y, Ogasawara N, et al. Precolumn fluores- cence derivatizafion of eamitine and aeylcarnitines with 4-( 2-amin- oethylamino) -7-nitro-2, 1,3-benzoxadiazole. J Chromatog A, 1994 ; 678 : 241 -247.
  • 7De W P, Deias R, Muck S, et al. High-performance liquid chromatog- raphy and capillary electrophoresis of L-and D-carnitine by precolunm diastereomerie defivatizafion. J Chromatog B, 1994; 57:67-73.
  • 8Engel AG,Franzini-Armstrong C.Myopathy[M].New York:McGraw Hill,1994:1587-1609
  • 9Lamhonwah AM,Olpin SE,Pollitt RJ,et al.Novel OCTN2 mutations:No genotype-phenotype correlations:Early carnitine therapy prevents cardiomyopathy[J].Am J Med Genet,2002,111:271-284
  • 10Takeyama N,Takagi D,Adachi K,et al.Measurement of free and esterified carnitine in tissue extracts by high performance liquid chromatography[J].Analytical Biochemistry,1986,158:346-354

共引文献37

同被引文献34

  • 1赵刚,凌林.HPLC法测定左旋卡尼汀氯化钠注射液含量及有关物质[J].安徽医药,2005,9(12):908-909. 被引量:1
  • 2USP 32 - NF 27 [ S]. 2009:2769.
  • 3SFDA(国家食品药品监督管理局).WSl-(X-023)-2005Z[S].2005.
  • 4CAO QR, REN S, PARK M J, et al. Determination of highly solu- ble L - carnitine in biological samples by reverse phase high per- formance liquid chromatography with fluorescent derivatization [ J ]. Arch Pharm Res,2007,30 ( 8 ): 1041.
  • 5D~tBROWSKA M, STAREK M. Analytical approaches to determi- nation of carnitine in biological materials ,foods and dietary supple- ments[ J]. Food Chem,2014,142:220.
  • 6EP 7. O[S]. 2011:2355.
  • 7B P 2009 [ S ]. 2009:1339.
  • 8Moselhy SS,Demerdash SH.Serum free L-camitine in as- sociation with myoglobin as a diagnostic marker of acute myocardial infarction[J].Clin Biochem, 2009,42 (1-2) : 78- 82.
  • 9屈明朗.番茄红素拮抗氧化应激诱导的神经元损伤及分子机制研究[D].重庆:第三军医大学,2012.
  • 10Neri S, Pistone G, Saraceno B ,et al.L-camitine decreas- es severity and type of fatigue induced by interferon-al- pha in the treatment of patients with hepatitis C[J].Neu- ropsychobiology, 2003,47 (2) : 94-97.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部